Evidence map›Paper›PMID 23099186›Full record

ArticleCell calcium2012

The luminal Ca(2+) chelator, TPEN, inhibits NAADP-induced Ca(2+) release.

Anthony J Morgan, John Parrington, Antony Galione

Open access · hybridAbstract read
In one paragraph

Article in Cell calcium, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Carvedilol inhibits cADPR- and IPMessenger (Los Angeles, Calif. : Print) · 2016
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anthony J MorganDepartment of Pharmacology, University of Oxford, Oxford, UK. anthony.morgan@pharm.ox.ac.uk
John Parrington
Antony Galione
University of Oxford · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The regulation of Ca(2+) release by luminal Ca(2+) has been well studied for the ryanodine and IP(3) receptors but has been less clear for the NAADP-regulated channel. In view of conflicting reports, we have re-examined the issue by manipulating luminal Ca(2+) with the membrane-permeant, low affinity Ca(2+) buffer, TPEN, and monitoring NAADP-induced Ca(2+) release in sea urchin egg homogenate. NAADP-induced Ca(2+) release was almost entirely blocked by TPEN (IC(50) 17-25μM) which suppressed the maximal extent of Ca(2+) release without altering NAADP sensitivity. In contrast, Ca(2+) release via IP(3) receptors was 3- to 30-fold less sensitive to TPEN whereas that evoked by ionomycin was essentially unaffected. The effect of TPEN on NAADP-induced Ca(2+) release was not due to an increase in the luminal pH or chelation of trace metals since it could not be mimicked by NH(4)Cl or phenanthroline. The fact that TPEN had no effect upon ionophore-induced Ca(2+) release also argued against a substantial reduction in the driving force for Ca(2+) efflux. We propose that, in the sea urchin egg, luminal Ca(2+) is important for gating native NAADP-regulated two-pore channels.

Indexed as

AnimalsCalciumCalcium SignalingChelating AgentsEthylenediaminesHydrogen-Ion ConcentrationInositol 1,4,5-Trisphosphate ReceptorsNADPOvumSea UrchinsCalciumChelating AgentsEthylenediaminesInositol 1,4,5-Trisphosphate ReceptorsNAADPNADPN,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine

Identifiers

PMID23099186
PMCPMC3526783
OpenAlexW1976913583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.